| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-173
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-14 |
| filingDate |
1995-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b56c29ef33b371c36eec86fbbb8ffd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daad1802703378443409ccbd32ad42f4 |
| publicationDate |
1996-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H08198797-A |
| titleOfInvention |
Taxol synthetic intermediate |
| abstract |
(57) [Summary] [Structure] General formula [Chemical formula 1] (R 1 , R 2 , R 3 and R 4 are each independently a hydroxyl-protecting group; X is a halogen atom). [Effect] Compared with the conventional method, taxol having excellent antitumor activity by passing through the intermediate of the present invention, It can be manufactured efficiently. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7399812-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006086913-A1 |
| priorityDate |
1995-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |